Jaguar Health (JAGX) Current Leases (2017 - 2026)
Jaguar Health (JAGX) posted quarterly Current Leases of $261000.0 for Q1 2026, down 4.4% year-over-year from $273000.0 in Q1 2025, and up 35.94% quarter-over-quarter from $192000.0 in Q4 2025.
Jaguar Health (JAGX) Current Leases (2017 - 2026) Analysis & Trends
Jaguar Health (JAGX) has reported Current Leases for 10 consecutive years, with $261000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Leases fell 4.4% year-over-year to $261000.0; the TTM figure through Mar 2026 stood at $261000.0 (down 4.4% YoY), while the FY2025 annual figure was $192000.0, down 35.79% from the prior year.
- Current Leases advanced to $261000.0 in Q1 2026 per JAGX's latest filing, from $192000.0 in the prior quarter.
- Across five years, Current Leases topped out at $526000.0 in Q3 2023 and bottomed at $192000.0 in Q4 2025.
- Historically, Current Leases has averaged $367176.5 across 5 years, with a median of $368000.0 in 2024.
- Annual changes were most pronounced in 2022 — Current Leases surged 101.25% — and 2025, when it tumbled 41.79%.
- Jaguar Health's Current Leases stood at $483000.0 in 2022, then retreated by 27.95% to $348000.0 in 2023, then fell by 14.08% to $299000.0 in 2024, then sank by 35.79% to $192000.0 in 2025, then soared by 35.94% to $261000.0 in 2026.
- Business Quant data shows JAGX's Current Leases at $261000.0 in Q1 2026, $192000.0 in Q4 2025, and $226000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.61 Bn | 131.75 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.70 Bn | 78.71 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 65.28 Bn | 60.09 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.14 Bn | 54.00 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.13 Bn | 37.03 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 31.83 Bn | 28.52 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 28.07 Bn | 9.68 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.54 Bn | 26.38 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | - |
| 10 | Jaguar Health | 448,735.56 | -9.62 Mn | 19.11 Mn | 261,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 261,000.00 |
| Dec 31, 2025 | 192,000.00 |
| Sep 30, 2025 | 226,000.00 |
| Jun 30, 2025 | 256,000.00 |
| Mar 31, 2025 | 273,000.00 |
| Dec 31, 2024 | 299,000.00 |
| Sep 30, 2024 | 368,000.00 |
| Jun 30, 2024 | 416,000.00 |
| Mar 31, 2024 | 469,000.00 |
| Dec 31, 2023 | 348,000.00 |
| Sep 30, 2023 | 526,000.00 |
| Jun 30, 2023 | 515,000.00 |
| Mar 31, 2023 | 503,000.00 |
| Dec 31, 2022 | 483,000.00 |
| Sep 30, 2022 | 418,000.00 |
| Jun 30, 2022 | 390,000.00 |
| Mar 31, 2022 | 299,000.00 |
| Dec 31, 2021 | 240,000.00 |
| Sep 30, 2021 | 297,000.00 |
| Jun 30, 2021 | 199,000.00 |